Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;106(7):1376-1389.
doi: 10.1097/TP.0000000000004012. Epub 2021 Dec 17.

Shotgun Immunoproteomics for Identification of Nonhuman Leukocyte Antigens Associated With Cellular Dysfunction in Heart Transplant Rejection

Katherine V Gates  1   2 , Anjali J Panicker  1   2   3   4   5   6   7   8 , Sherri M Biendarra-Tiegs  4 , Nikolai G Vetr  5 , Manuela Lopera Higuita  2 , Timothy J Nelson  4   6   7   8 , Naveen L Pereira  2 , Leigh G Griffiths  2
Affiliations

Shotgun Immunoproteomics for Identification of Nonhuman Leukocyte Antigens Associated With Cellular Dysfunction in Heart Transplant Rejection

Katherine V Gates et al. Transplantation. .

Abstract

Background: The International Society for Heart and Lung Transplant consensus panel notes that too little data exist regarding the role of non-HLA in allograft rejection. We developed a novel shotgun immunoproteomic approach to determine the identities and potential roles non-HLA play in antibody-mediated rejection (AMR) in heart transplant recipients.

Methods: Serum was collected longitudinally from heart transplant recipients experiencing AMR in the absence of donor-specific anti-HLA antibodies (n = 6) and matched no rejection controls (n = 7). Antidonor heart affinity chromatography columns were formed by recipient immunoglobulin G immobilization at transplantation, acute rejection, and chronic postrejection time points. Affinity chromatography columns were used to capture antigens from individual patient's donor heart biopsies collected at transplantation. Captured proteins were subjected to quantitative proteomic analysis and the longitudinal response was calculated.

Results: Overlap in antigen-specific response between AMR and non-AMR patients was only 8.3%. In AMR patients, a total of 155 non-HLAs were identified, with responses toward 43 high prevalence antigens found in ≥50% of patients. Immunofluorescence staining for representative high prevalence antigens demonstrated that their abundance increased at acute rejection, correlating with their respective non-HLA antibody response. Physiological changes in cardiomyocyte and endothelial cell function, following in vitro culture with patient immunoglobulin G, correlated with response toward several high prevalence antigens.

Conclusions: This work demonstrates a novel high-throughput strategy to identify clinically relevant non-HLA from donor endomyocardial biopsy. Such a technique has the potential to improve understanding of longitudinal timing of antigen-specific responses and their cause and effect relationship in graft rejection.

PubMed Disclaimer

Conflict of interest statement

Mayo Clinic and T.J.N. have financial rights to ReGen Theranostics through licensing agreements. The remaining authors have no relevant conflicts of interest to disclose.

Comment in

References

    1. Singh TP, Milliren CE, Almond CS, et al. Survival benefit from transplantation in patients listed for heart transplantation in the United States. J Am Coll Cardiol. 2014;63:1169–1178.
    1. Wong KL, Taner T, Smith BH, et al. Importance of routine antihuman/leukocyte antibody monitoring: de novo donor specific antibodies are associated with rejection and allograft vasculopathy after heart transplantation. Circulation. 2017;136:1350–1352.
    1. Uber WE, Self SE, Van Bakel AB, et al. Acute antibody-mediated rejection following heart transplantation. Am J Transplant. 2007;7:2064–2074.
    1. Costanzo MR, Dipchand A, Starling R, et al.; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–956.
    1. Crespo-Leiro MG, Barge-Caballero E, Paniagua-Martin MJ, et al. Update on immune monitoring in heart transplantation. Curr Transplant Rep. 2015;2:329–337.

Publication types